Ma-sha Huang
Hunan Key Laboratory Of Pharmacogenetics
Changsha, China
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
DCBLD2 Affects the Development of Colorectal Cancer via EMT and Angiogenesis and Modulates 5-FU Drug Resistance.
Journal: Frontiers in cell and developmental biology
Published: February 18, 2021
Response prediction biomarkers and drug combinations of PARP inhibitors in prostate cancer.
Journal: Acta pharmacologica Sinica
Published: July 10, 2020
Hsa_circ_0001946 Inhibits Lung Cancer Progression and Mediates Cisplatin Sensitivity in Non-small Cell Lung Cancer via the Nucleotide Excision Repair Signaling Pathway.
Journal: Frontiers in oncology
Published: February 25, 2019
Nucleolar and spindle-associated protein 1 is a tumor grade correlated prognosis marker for glioma patients.
Journal: CNS neuroscience & therapeutics
Published: August 28, 2017
Long noncoding RNA SFTA1P promoted apoptosis and increased cisplatin chemosensitivity via regulating the hnRNP-U-GADD45A axis in lung squamous cell carcinoma.
Journal: Oncotarget
Published: July 28, 2017
Prognostic and predictive values of CDK1 and MAD2L1 in lung adenocarcinoma.
Journal: Oncotarget
Published: August 23, 2016
Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer.
Journal: International journal of molecular sciences
Published: March 28, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026